Changli Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- PI3K/AKT/mTOR signaling in cancer
- Epigenetics and DNA Methylation
Papers in
-
- Circular RNAs in diseases 2
-
- Cancer-related molecular mechanisms research 6
- MicroRNA in disease regulation 6
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Ke Xu (1 shared paper)Xiang Wu (1 shared paper)Boning Liu (1 shared paper)Qinghua Zhou (1 shared paper)Yunde Liu (1 shared paper)Bin Liu (1 shared paper)Rui Jia (2 shared papers)Yanjun Su (3 shared papers)
- Journals
- International Journal of Molecular Sciences (4 papers)Frontiers in Oncology (3 papers)Frontiers in Psychiatry (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)Biochemical and Biophysical Research Communications (1 paper)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Changli Wang
30 papers receiving 491 citations
Peers
Comparison fields: 5 of 69
- Cancer Research 246
- Molecular Biology 278
- Rehabilitation 13
- Oncology 48
- Molecular Medicine 8
Countries citing papers authored by Changli Wang
This map shows the geographic impact of Changli Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changli Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changli Wang more than expected).
Fields of papers citing papers by Changli Wang
This network shows the impact of papers produced by Changli Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changli Wang. The network helps show where Changli Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Changli Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 163 | |
| 2 | 2018 | 54 | |
| 3 | 2016 | 47 | |
| 4 | 2019 | 33 | |
| 5 | 2024 | 29 | |
| 6 | 2018 | 23 | |
| 7 | 2020 | 23 | |
| 8 | 2023 | 22 | |
| 9 | 2024 | 14 | |
| 10 | 2019 | 10 | |
| 11 | 2024 | 9 | |
| 12 | 2015 | 9 | |
| 13 | 2021 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2025 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2025 | 5 | |
| 18 | 2022 | 5 | |
| 19 | 2022 | 4 | |
| 20 | 2014 | 3 |
About Changli Wang
Changli Wang is a scholar working on Molecular Biology, Cancer Research, Immunology, Biotechnology and Mechanics of Materials, having authored 33 papers that have together received 493 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (6 papers), MicroRNA in disease regulation (6 papers), Advanced Numerical Analysis Techniques (3 papers), Cancer Genomics and Diagnostics (3 papers), Cancer Research and Treatments (3 papers), Cancer, Hypoxia, and Metabolism (2 papers), Galectins and Cancer Biology (2 papers) and Circular RNAs in diseases (2 papers). The work is most often cited by research in Cancer Research (246 citations), Molecular Biology (278 citations), Rehabilitation (13 citations), Oncology (48 citations) and Molecular Medicine (8 citations). Changli Wang has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Ke Xu, Xiang Wu, Boning Liu, Qinghua Zhou, Yunde Liu, Bin Liu, Rui Jia, Yanjun Su, Zhenfa Zhang and Leina Sun. Their work appears in journals such as International Journal of Molecular Sciences, Frontiers in Oncology, Frontiers in Psychiatry, Frontiers in Bioengineering and Biotechnology and Biochemical and Biophysical Research Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.